Real Peptides Thymosin Alpha-1 vs Competitors Quality: Comparison
Synthesis Method Small-batch Fmoc-SPPS with per-residue coupling verification Liquid-phase or large-batch SPPS without step verification Bulk liquid-phase synthesis, batch sizes >100g Small-batch SPPS is the only method that guarantees sequence fidelity. Bulk
This comparison does not assign a generated winner or score.
- Synthesis Method
- Small-batch Fmoc-SPPS with per-residue coupling verification
- Liquid-phase or large-batch SPPS without step verification
- Bulk liquid-phase synthesis, batch sizes >100g
- Small-batch SPPS is the only method that guarantees sequence fidelity. Bulk synthesis introduces substitution errors that standard testing misses
- Sequence Verification
- MS/MS fragmentation + Edman sequencing on every batch
- Mass spec for molecular weight only
- No sequence-level testing. CoA shows HPLC purity only
- Full-sequence confirmation (MS/MS or Edman) is the only way to detect positional substitutions. Molecular weight alone is insufficient
- Purity Standard
- ≥99% via HPLC, verified by independent third-party lab
- 95–98% via in-house HPLC, no third-party verification
- 90–95% purity, synthesis byproducts not characterized
- Third-party verification eliminates supplier bias. In-house CoAs are not independently validated
- Cold-Chain Shipping
- Insulated packaging + temperature data loggers, replacement guarantee if temp exceeds 8°C
- Standard ground shipping, no temperature monitoring
- No cold-chain protocol. Ships at ambient temperature
- Temperature excursions during shipping cause irreversible racemization and aggregation. Unmonitored shipping is a quality failure regardless of synthesis method
- Reconstitution Protocol
- Detailed protocol with bacteriostatic water volume, pH verification, and storage instructions
- Generic instructions or none provided
- No protocol provided
- Incorrect reconstitution (wrong pH, excessive agitation, non-sterile water) degrades peptide faster than poor synthesis. Protocol clarity matters
- Price Per mg (10mg vial)
- $42–48/mg
- $18–28/mg
- $8–15/mg
- Price directly reflects synthesis batch size and QC depth. Peptides under $20/mg for research-grade thymosin alpha-1 are almost certainly bulk-synthesized without sequence verification